Skip to content
Government WA, Medical Health Aged Care

WA women to have permanent access to UTI care through pharmacists

Pharmaceutical Society of Australia (PSA) 2 mins read

4 August 2023

The Pharmaceutical Society of Australia (PSA) welcomes the West Australian Government’s commitment to improving access to care for thousands of women suffering from urinary tract infections each year.

From today, 4 August 2023, pharmacists who have undergone specific training will be able to prescribe antibiotics for uncomplicated urinary tract infections (UTIs) in patients aged 18 to 65 years old. The training is now available to all WA pharmacists.

PSA Western Australia President Kristian Ray welcomed the move, saying that patient’s access to care should be front of mind.

“Pharmacists are well positioned to play a greater role in primary health care and will make UTI treatments more accessible for more West Australians,” Mr Ray said.

“There are hundreds of thousands of women living in Western Australia that will benefit from this policy, particularly in rural and remote WA where there are significant barriers to accessing timely care.

“This program is about improving access to care where it is clinically appropriate, and working with the rest of the primary care team to promote a collaborative care model for Western Australians.

“There are robust referral pathways in place for patients who suffer from recurring UTIs, or might fall outside of the clinical inclusion criteria.

“As some of the most accessible healthcare professionals, pharmacists play a vital role in supporting the health and wellbeing of our communities.

“As pharmacists, we are committed to working collaboratively with the entire health sector to deliver best outcomes for patients.

“I am looking forward to working closely with the Government to ensure the success of the program, improving access to safe, timely care,” Mr Ray concluded.

PSA's Managing Uncomplicated Cystitis (Urinary Tract Infection) training program is now available to all WA pharmacists.

 

Media contact:   Georgia Clarke   M: 0480 099 798      E: [email protected]

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s 36,000 pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system.

Follow us on socials:      Facebook     Twitter      LinkedIn     Instagram

More from this category

  • Medical Health Aged Care
  • 15/08/2026
  • 07:02
Optimi Health Corp.

Optimi Health Establishes Discretionary Equity Facility

VANCOUVER, British Columbia, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the “Company” or “Optimi”), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced that it has entered into a common shares purchase agreement (the “Purchase Agreement”) with Seven Knots, LLC (“Seven Knots”), establishing an equity line of credit (the “ELOC”) under which the Company has the right, but not the obligation, to sell to Seven Knots up to US$100 million of its common shares from time to time over the term of the facility.Sales under the ELOC are at the…

  • Medical Health Aged Care, Research Development
  • 14/08/2026
  • 08:00
Australia New Zealand Gynaecological Oncology Group (ANZGOG)

ANZGOG opens 2026 Fund for New Research Grants to accelerate the next generation of gynaecological cancer research

MEDIA RELEASE Friday, 14 August 2026 ANZGOG opens 2026 Fund for New Research Grants to accelerate the next generation of gynaecological cancer research The Australia New Zealand Gynaecological Oncology Group (ANZGOG) has today opened applications for its 2026 Fund for New Research Grant Program, supporting researchers to investigate promising ideas and generate the evidence needed to progress larger studies and future clinical trials. Supported by significant contributions from ANZGOG donors, the 2026 program will fund four priority research areas, with grants ranging from $50,000 to $100,000: Endometrial cancer focused surgical study – one grant of up to $55,000 Leiomyosarcoma focused…

  • Animal Animal WelfareRights, Medical Health Aged Care
  • 13/08/2026
  • 10:30
Monash University

Monash experts: Avian Influenza

Monash University experts are available to discuss the spread of H5 bird flu and its implications across native bird populations, agriculture, farming and general preparedness. Professor Anne Peters, specialist in the behaviour ecology and conservation of birds, Deputy Head of School of Biological Sciences,Monash University Contact details: +61 3 9903 4840 or [email protected] Read more Analysis and Opinion from Professor Peters The following can be attributed to Professor Peters: “Regarding theflu being detected in silver gulls, this is obviously very concerning. These seagulls are what many people know as the 'fish & chip' gull, i.e. they are common, range widely,…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.